SILLAJEN BIOTHERAPEUTICS Trademark

Trademark Overview

On Monday, June 23, 2014, a trademark application was filed for SILLAJEN BIOTHERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the SILLAJEN BIOTHERAPEUTICS trademark a serial number of 86980714. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 30, 2023. This trademark is owned by SillaJen Biotherapeutics, Inc.. The SILLAJEN BIOTHERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Biopharmaceutical agents in the form of oncolytic viruses for the prevention, diagnosis, and treatment of cancer; biologic pharmaceutical preparations for the prevention, diagnosis, and treatment of cancer
sillajen biotherapeutics

General Information

Serial Number86980714
Word MarkSILLAJEN BIOTHERAPEUTICS
Filing DateMonday, June 23, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 30, 2023
Registration Number5106638
Registration DateTuesday, December 20, 2016
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 24, 2015

Trademark Statements

Goods and ServicesBiopharmaceutical agents in the form of oncolytic viruses for the prevention, diagnosis, and treatment of cancer; biologic pharmaceutical preparations for the prevention, diagnosis, and treatment of cancer
NOT AVAILABLE"BIOTHERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 30, 2023
Primary Code005
First Use Anywhere DateFriday, May 27, 2016
First Use In Commerce DateFriday, May 27, 2016

Trademark Owner History

Party NameSillaJen Biotherapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94111
Party NameSillaJen Biotherapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94111
Party NameSillaJen Biotherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94111

Trademark Events

Event DateEvent Description
Tuesday, September 30, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 26, 2014NEW APPLICATION ENTERED
Monday, June 30, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 29, 2014ASSIGNED TO EXAMINER
Tuesday, September 30, 2014NON-FINAL ACTION E-MAILED
Tuesday, September 30, 2014NON-FINAL ACTION WRITTEN
Tuesday, December 9, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 9, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 10, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 31, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 21, 2015ASSIGNED TO LIE
Wednesday, January 21, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 4, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 24, 2015PUBLISHED FOR OPPOSITION
Tuesday, February 24, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 21, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 20, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 20, 2015SOU EXTENSION 1 GRANTED
Tuesday, October 20, 2015SOU TEAS EXTENSION RECEIVED
Tuesday, October 20, 2015SOU EXTENSION 1 FILED
Thursday, October 22, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 1, 2015TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 1, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, April 11, 2016SOU TEAS EXTENSION RECEIVED
Monday, April 11, 2016SOU EXTENSION 2 FILED
Wednesday, May 11, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 11, 2016SOU EXTENSION 2 GRANTED
Thursday, May 12, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 20, 2016TEAS STATEMENT OF USE RECEIVED
Thursday, October 20, 2016TEAS REQUEST TO DIVIDE RECEIVED
Thursday, October 20, 2016DIVISIONAL REQUEST RECEIVED
Thursday, October 20, 2016USE AMENDMENT FILED
Wednesday, October 26, 2016DIVISIONAL PROCESSING COMPLETE
Wednesday, October 26, 2016STATEMENT OF USE PROCESSING COMPLETE
Tuesday, December 20, 2016REGISTERED-PRINCIPAL REGISTER
Friday, March 26, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 16, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, November 17, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, March 26, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 26, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 26, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, March 26, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 20, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, June 30, 2023CANCELLED SEC. 8 (6-YR)

Related Keywords

biotherapeutics sillajen treatment cancer diagnosis prevention biologic pharmaceutical preparations agents form biopharmaceutical